ACHC
Acadia Healthcare Company, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $144.2M | first quarter ended March 31, 2026 | — |
| Newly licensed beds added | 82 | first quarter ended March 31, 2026 | — |
| Newly licensed beds added from newly constructed facilities | 40 | first quarter ended March 31, 2026 | — |
| Newly licensed beds added to existing facilities | 42 | first quarter ended March 31, 2026 | — |
| Patient days growth | 1.6% | first quarter ended March 31, 2026 | — |
| Revenue per patient day growth | 5.6% | first quarter ended March 31, 2026 | — |
| Same-facility revenue growth | 7.3% | first quarter ended March 31, 2026 | — |
| facilities | 275 | Q1 FY2026 call | — |
| net leverage ratio | 3.9 | Q1 FY2026 call | — |
| net operating costs associated with closed facilities | $3M | Q1 FY2026 call | — |
| patients served daily | 84,000 | Q1 FY2026 call | — |
| same-facility adjusted EBITDA non-GAAP | $199.5M | Q1 FY2026 call | — |
| same-facility patient days growth | 1.6% | Q1 FY2026 call | — |
| same-facility revenue per patient day growth | 5.6% | Q1 FY2026 call | — |
| start-up facility losses | $12M | Q1 FY2026 call | — |
| Adjusted net income non-GAAP | $182.7M | Full Year 2025 | — |
| Newly licensed beds | 1,089 | Full Year 2025 | — |
| Patient days | 3.1% | Q4 2025 | — |
| Revenue per patient day | 1.3% | Q4 2025 | — |
| Same facility revenue | 4.4% | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACHC
this stock
Acadia Healthcare Company, Inc.
|
$2.87B | +119.1% | +12.2% | — | 22.0% |
|
HCA
HCA Healthcare, Inc.
|
$94.07B | -10.5% | +7.1% | 14.6 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.14B | -12.8% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.99B | +5.1% | -2.3% | 10.9 | 4.7% |
|
DVA
Davita Inc.
|
$15.04B | +106.2% | +6.5% | 22.0 | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACHC | +13.4% | +23.3% | +129.8% | +5.3% | +119.1% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | +10.3% | +24.1% | +121.6% | +4.7% | +108.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.